Numeric Investors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Numeric Investors’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$6.71M	Buy	374,920 +141,800	+61%	+$2.96M	0.05%	359
2017 Q3	$5.85M	Sell	233,120 -34,480	-13%	-$803K	0.05%	373
2017 Q2	$6.45M	Buy	+267,600	New	+$5.92M	0.06%	290
2016 Q4	–	Sell	-183,491	Closed	-$2.39M	–	1219
2016 Q3	$2.39M	Sell	183,491 -128,164	-41%	-$1.7M	0.02%	444
2016 Q2	$4.33M	Buy	+311,655	New	+$4.59M	0.04%	318
2013 Q3	–	Sell	-1,832	Closed	-$66K	–	927
2013 Q2	$66K	Buy	+1,832	New	+$78.5K	﹤0.01%	756

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Numeric Investors's PRTK Position: Q4 2017 in Review

Numeric Investors increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 61% in Q4 2017, buying an estimated $2.96M and bringing the position to 374,920 shares worth $6.71M. The position accounts for 0.05% of the portfolio, ranked #359.

Numeric Investors first reported a position in PRTK in Q2 2013 and has held it in 6 quarters since. 116 funds tracked by Wall St. Rank hold PRTK as of Q4 2017.

Numeric Investors held 374,920 shares of Paratek Pharmaceuticals, Inc. worth $6.71M as of Q4 2017.
Numeric Investors bought 141,800 Paratek Pharmaceuticals, Inc. shares in Q4 2017, an estimated $2.96M.
Paratek Pharmaceuticals, Inc. made up 0.05% of Numeric Investors's portfolio in Q4 2017, its #359 holding.
Numeric Investors first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and has held it in 6 quarters since.
116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.